The pharmacovigilance market is driven by several factors, including the increasing incidence of adverse drug reactions, the growing demand for pharmacovigilance services from regulatory agencies, and the rising number of drug approvals. The market is also supported by advancements in technology, including the use of artificial intelligence and machine learning in adverse event monitoring and...